Value, Access and Regulatory Strategy Workshop Basel, Switzerland 25-26 October 2017

Description:
Leaders across industry and health authorities agree that finding answers to market access are critical to the future of delivering breakthrough medicines to patients. Unfortunately, policies and practice do not always marry up.

This meeting is the starting point to engage professionals working with value and regulatory strategies. HTA bodies and regulators are breaking down silos, facilitating access to new medicines and increasing efficiencies in assessment processes. RandD process will need to be able to generate evidence for registration and reimbursement.

Bringing together the policy makers and the policy implementers, to keep you ahead of the game of practical solutions.

Booking: https://go.evvnt.com/138348-1

Time: 09:00 to 16:00

Price:
Member Early-Bird: EUR 1230,
Member Advance Rate: EUR 1330,
Member Industry: EUR 1430,
Non-Member Industry: EUR 1585,
Member Government/Charitable/Non-profit/Academia (Full-Time): EUR 715,
Non-member Government/Charitable/Non-profit/Academia (Full-Time): EUR 870

Speakers: Solange Corriol-Rohou (Senior Director, Globar RA and Policy, Astrazeneca), Angelika Joos (ED, Global Regulatory Policy, MSD), Katarzyna Kolasa (Senior Project Sales Director, Health Economics and Outcomes Research, GE Healthcare), Mira Pavlovic (Founder, MDT Services), Claudine Sapede (Global HTA and Payment Policy Lead, F. Hoffmann-La Roche)